Radiomics is well placed to make clinically effective and cost-effective contributions to cancer care as a decision-making tool for personalised medicine. However, a systematic evaluative framework needs to be established so that these benefits can be demonstrated with confidence.
CITATION STYLE
Miles, K. (2020, March 31). Radiomics for personalised medicine: the long road ahead. British Journal of Cancer. Springer Nature. https://doi.org/10.1038/s41416-019-0699-8
Mendeley helps you to discover research relevant for your work.